Delivery Order SPE2DB24D1205-SPE2DB24FCTZZ
Award Date
8/22/24
Potential Completion Date
8/23/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,541.59 firm fixed-price delivery order is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a type of pharmaceutical product. The contract has an ultimate completion date of July 18, 2024. Amerisourcebergen Drug Corp is a large pharmaceutical distributor that has been awarded numerous government contracts, including Indefinite Delivery Contracts...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML. The $7,663.04 firm fixed-price delivery order contract has a completion date of September 9, 2024 and does not utilize a set-aside designation. As a vendor-managed inventory, distribution, and destruction services provider, AmerisourceBergen has been awarded multiple Indefinite Delivery...
This federal contract award is a delivery order valued at $1,093.56 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a specialty medication, with an ultimate completion date of December 9, 2024. Amerisourcebergen, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medication. The $1,600.08 Firm Fixed Price Delivery Order has an ultimate completion date of August 26, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract, with a ceiling value of $7,375.29, is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the U.S., has...
This federal contract award is for $1,031.85 and was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a delivery order for the procurement of GVOKE HYPOPEN 1-PK 1 MG/0.2 ML 0.2ML, a pharmaceutical product. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including to military treatment facilities, veterans'...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award, a firm fixed price Delivery Order with a ceiling value of $2,052.71, is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML pharmaceutical products. The contract does not have a set-aside designation and is intended to support military treatment programs and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,531.33 firm fixed price delivery order is for the supply of GVOKE PFS 1-PK 1 MG/0.2 ML SYR 0.2ML, a specialty medication. The award has an ultimate completion date of August 2, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a pharmaceutical product. The contract has a ceiling value of $3,754.49 and a performance period through March 11, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery order, which is not part of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,468.52 delivery order contract is for the supply of GVOKE HYPOPEN 2PK 0.5MG/0.1 ML 0.1ML, a medical product. The contract has a firm fixed-price pricing type and a completion date of May 9, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...